BioXcel Therapeutics, Inc. (BTAI) Income Annual - Discounting Cash Flows
BTAI
BioXcel Therapeutics, Inc.
BTAI (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
Report Filing 2025-05-12 2025-03-28 2024-03-22 2023-05-01 2022-03-11 2021-03-12 2020-03-09 2019-03-12 2017-12-31 2016-12-31 2015-12-31
Revenue 1.85 2.27 1.38 0.375 0 0 0 0 0 0 0
Cost of Revenue 2.06 2.14 1.26 0.02 0.297 0.188 0.156 0.017 0.001 0 0
Gross Profit -0.212 0.123 0.12 0.355 -0.297 -0.188 -0.156 -0.017 -0.001 0 0
Operating Expenses 54.8 67.37 171.9 160 106.6 82.11 33.45 19.95 4.54 2.12 0.636
Research & Development 23.59 30.43 84.33 91.24 52.71 57.99 25.8 14.56 2.69 1.4 0.233
Selling, General and Administrative 25.05 34.49 83.41 68.76 54.23 24.3 7.8 5.4 1.85 0.721 0.403
Other Operating Expenses 6.16 2.44 4.16 0 -0.297 -0.188 -0.156 -0.017 -0.001 0 0
Operating Income -55.01 -67.25 -171.8 -159.6 -106.9 -82.3 -33.6 -19.96 -4.54 -2.12 -0.636
Net Non-Operating Interest -8.81 -12.53 -7.67 -5.68 -0.036 0.128 0.633 0 -0.002 0 0
Interest Income 2.71 2.6 5.65 2.53 0.004 0.155 0.633 0 0 0 0
Interest Expense 11.52 15.13 13.31 8.21 0.04 0.027 0 0 0.002 0 0
Equity & Other Income/(Expense) 23.77 20.17 0.394 -0.427 0.04 0 0 0.692 0 0 0
Income Before Tax -40.06 -59.6 -179.1 -165.8 -106.9 -82.17 -32.97 -19.27 -4.54 -2.12 -0.636
Income Tax Expense 0 0 0 6.09 -0.301 -0.161 -0.633 0.692 0 -2.12 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 -0.692 0 2.12 0
Net Income -40.06 -59.6 -179.1 -171.8 -106.6 -82.01 -32.34 -19.27 -4.54 -2.12 -0.636
Depreciation and Amortization 0.63 0.309 0.318 0.327 0.297 0.188 0.156 0.017 0.001 2.12 0
EBITDA -54.38 -66.94 -171.5 -159.3 -106.6 -82.11 -33.45 -19.95 -4.54 0 -0.636
Earnings Per Share (EPS) -5.89 -23.51 -6.15 -6.13 -4.04 -3.78 -1.99 -1.32 -0.3 -0.14 -0.04
Diluted Earnings Per Share -5.89 -23.51 -6.15 -6.13 -4.04 -3.78 -1.99 -1.32 -0.3 -0.14 -0.04
Weighted Average Shares Outstanding 38.34 2.54 29.13 28.02 26.37 21.68 16.29 14.57 15.19 15.65 15.94
Diluted Weighted Average Shares Outstanding 38.34 2.54 29.13 28.02 26.37 21.68 16.29 14.57 15.19 15.65 15.94
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us